# DESCRIPTION

## TECHNICAL FIELD OF THE INVENTION

- introduce antibacterial compositions

## BACKGROUND OF THE INVENTION

- describe antibiotic resistance
- introduce helper compounds

## SUMMARY OF THE INVENTION

- disclose cannabidiol as helper compound
- describe synergy with bacitracin and daptomycin
- outline potential treatments

## DETAILED DESCRIPTION OF THE INVENTION

- define cannabidiol
- define bacitracin
- define daptomycin
- describe composition with cannabidiol and bacitracin
- describe composition with cannabidiol and daptomycin
- describe functional equivalents to bacitracin
- describe composition with cannabidiol and kanamycin
- describe composition with cannabidiol and polymyxin
- outline concentrations of components
- describe forms of composition
- describe further components
- describe carrier or encapsulating vehicle
- describe absence of THC
- describe additional antibiotics
- describe metal ions
- describe lubricant and/or moisture insulator
- describe source of cannabidiol
- describe pharmaceutical composition

## EXAMPLES

### Combining Cannabidiol with Antibiotics

- introduce study aim
- describe materials and methods
- explain MIC and FIC index calculations
- present results of growth experiments
- calculate FIC indices for antibiotic combinations
- conclude synergy between CBD and antibiotics

### Example 2

- study bacterial spectrum of CBD and bacitracin on Gram-positive bacteria

### Example 3

- study bacterial spectrum of CBD and bacitracin on Gram-negative bacteria

### Example 4

- investigate synergy for other members of the cannabinoid family

### Example 5

- study triple combination of CBD, daptomycin, and bacitracin on Gram-positive bacteria

### Example 6

- study CBD with kanamycin on Pseudomonas aeruginosa and with polymyxin B on Salmonella typhimurium and Es

